Synergistic Effects of Arsenic Trioxide and Silibinin on Apoptosis and Invasion in Human Glioblastoma U87MG Cell Line

Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix metalloproteinase 9

(2010) Majid Momeny et al.   ANTI-CANCER DRUGS

Recent Advances in Therapy for Glioblastoma

(2010) Jennifer Clarke et al.   ARCHIVES OF NEUROLOGY

Potential therapeutic implications of cancer stem cells in glioblastoma

(2010) Lin Cheng et al.   BIOCHEMICAL PHARMACOLOGY

Differential role of cathepsins B and L in autophagy-associated cell death induced by arsenic trioxide in U87 human glioblastoma cells

(2010) Anja Pucer et al.   BIOLOGICAL CHEMISTRY

Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer

(2010) Gagan Deep et al.   CANCER AND METASTASIS REVIEWS

Advances in the Treatment of Malignant Gliomas

(2010) Mustafa Khasraw et al.   Current Oncology Reports

Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide

(2008) Tseng-Hsi Lin et al.   BMC CANCER

Multitargeted therapy of cancer by silymarin

(2008) Kumaraguruparan Ramasamy et al.   CANCER LETTERS

Autophagy in the Pathogenesis of Disease

(2008) Beth Levine et al.   CELL

Nuclear survivin expression predicts poorer prognosis in glioblastoma

(2008) Katsuyuki Shirai et al.   JOURNAL OF NEURO-ONCOLOGY

Arsenic trioxide mechanisms of action – looking beyond acute promyelocytic leukemia

(2008) Dennis A. Carney   LEUKEMIA & LYMPHOMA

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols

Dual contrasting roles of cysteine cathepsins in cancer progression: Apoptosis versus tumour invasion

(2007) Olga Vasiljeva et al.   BIOCHIMIE